Objective and design: We investigated the impact of the fatness-related FTO rs9939609 A-allele on cross-sectional and longitudinal measures of body mass index (BMI), height and lean body mass (LBM) in a unique cohort representing a broad range of BMI. Subjects and measurements: A random sample of all men attending the Danish draft boards during 1943-1977 plus all men with a BMIX31.0 kg/m 2 (assuring representation of the right end of the distribution) was taken. Anthropometric measures were available at up to eight points in time from birth to adulthood in 1629 genotyped men. The odds ratio (OR) for being a carrier of FTO rs9939609 according to (1) one unit alteration in z-scores for BMI, height and LBM at given ages and (2) longitudinal changes in BMI and height z-scores were assessed by logistic regression. Results: Except at birth, the AA genotype was associated with increased BMI z-scores at all point during the monitored lifespan, starting at the age of 7 years. This effect remained stable until early adulthood, where further weight gain occurred. The AA genotype was alsoFmainly through the effect on fatnessFassociated with accelerated linear growth in childhood (age 7 years; OR, 1.36; 95% confidence interval (CI), 1.06-1.74) and increased LBM in adulthood (OR, 1.24; 95% CI, 1.14-1.35). Conclusion: Fatness induced by FTO rs9939609 in early childhood is sustained until early adulthood, where further weight gain may occur. FTO rs9939609 may, however, also be associated with linear growth and LBM mainly through the effect on fat mass.
Introduction
The prevalence of obesity is increasing worldwide, not least among children. In Europe and North America, more than 20% of children are now overweight with a substantial part being severely obese. 1, 2 The aetiology of obesity is thought to be multi-factorial, as twin and adoption studies have disclosed a significant genetic component in the development of this trait, 3 whereas the rapidly increasing prevalence of obesity worldwide inevitably reflects changes in exposure to environmental factors, most likely acting early in life and possibly through epigenetic mechanisms. 4, 5 Increasing activity within the field of genome-wide association studies for disease susceptibility genes has recently led to the identification of a common variant of FTO (rs9939609 T/A; minor A-allele frequency (MAF) in Caucasians, 0.45), which predisposes to type 2 diabetes through an effect on body mass index (BMI, kg/m 2 ). 6 Subsequent studies of large European study populations have confirmed a highly significant association between different variants of FTO and fatness, both among children and adults and independent of gender. [6] [7] [8] As no studies so far have assessed these variants in a single population followed longitudinally from birth through adulthood, it remains unknown whether the effect of FTO on BMI remains stable during the life course. Studies of the obesity-related melanocortin 4 receptor gene have shown that genetically determined fatness may be accompanied by increase in lean body mass (LBM) and in linear growthFpossibly due to excess secretion of growth hormone or to hyperinsulinemia. 9 These findings are in accordance with studies reporting a general association between obesity, LBM and growth. 10, 11 As carriers of the A-allele of FTO rs9939609 are predisposed to fatness and type 2 diabetes, they may also be expected to have fatnessinduced accelerated linear growth and increased LBM. The aim of this study was to assess the impact of FTO rs9939609 (1) on weight dynamics throughout life, using repetitive assessments of individuals belonging to a Danish population of men representing a very wide range of BMI and followed from birth to middle age, and (2) on general growth, using repetitive measurements of height and LBM from the same study population.
Materials and methods

Study population and measurements
A total of 362 200 Danish men underwent a mandatory draft board examination in Copenhagen during 1943-1977 and in the remainder of Zealand during [1964] [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] [1976] [1977] . Among these, a study population consisting of a randomly selected 1.0% sample (n ¼ 3601) and all men with a BMI equal to or above 31 kg/m 2 (n ¼ 1930) was sampled manually from draft board files during the 1970s. The latter group represented all 35% overweight men according to a national standard in use when the participants were identified (all above the 99th percentile of the BMI distribution). They were included in the study population to obtain a much wider range of BMI than in usual sampling techniques. A follow-up study was planned in the early 1980s in collaboration with the Copenhagen City Heart Study, running their second survey at that time. For logistic and cost reasons, only 50% of the randomly selected group and all obese men were invited. A total of three follow-up surveys were conducted during 1981-1983 (mean age, 35 years), 1992-1994 (mean age, 46 years) and 1998-2000 (mean age, 49 years). [12] [13] [14] In this study, these surveys will be referred to as S-35, S-46 and S-49. Using blood samples obtained at S-46, 1629 (753 originally obese and 876 randomly sampled) men were genotyped. Among them, 1327 were assessed in S-35 and 551 were assessed in S-49. From school health records, anthropometric measurements from birth (n ¼ 328) and childhood (age 7 years, n ¼ 381; age 10 years, n ¼ 380; age 13 years, n ¼ 372) were available. 15 LBM and fat mass were assessed through bioimpedance in S-46 and by dual-energy x-ray absorptiometry (DXA) in S-49. Measurement of anthropometrics has been described in further detail elsewhere. [13] [14] [15] [16] Local Ethics
Committees approved all these studies. This pattern is probably due to the enriched sampling of the most obese in adolescence. However, as most studies have indicated a co-dominant transmission, we also analysed the data on the basis of this model. Age-specific z-scores were used to allow comparison between age groups and were calculated as deviation from mean values in standard deviation units within each age group, with the random sample serving as the reference population at each age.
Genetic analysis
Owing to the sampling design and pooling of the two cohorts with a massive enrichment of the right tail of the BMI distribution, data could not be analysed with BMI or BMI-associated outcomes as response variables in a common regression model. Also, use of a dichotomized case-control approach would waste considerable statistical efficiency otherwise gained by using the quantitative phenotypes. Hence, to take advantage of the wide range of BMI, analyses were reversed to examine the probability of carrying the AA genotype according to one unit changes in (1) BMI z-score at each of the given ages, (2) longitudinal changes in BMI z-score (that is, changes from one age to another), (3) height z-score at given ages, (4) longitudinal changes in height z-score and (5) z-score for LBM and fat mass at S-46 and S-49.
In other words, z-scores for phenotypes were treated as continuous exposure variables, whereas the AA genotype was the outcome. As an example, an OR of 1.22 for being a carrier of the AA genotype according to BMI z-score at the age of FTO variant, weight dynamics and growth T Jess et al 7 years should be interpreted as an increment in odds of 22% for being a carrier of the AA genotype per one unit positive deviation from mean BMI z-score at that age. Longitudinal analyses of one unit changes in z-scores from one age to another should be similarly interpreted.
Longitudinal analyses of FTO and changes in BMI z-score from one age to another were adjusted for BMI z-score at baseline as the two measures were correlated (data not shown). In additional analyses, BMI z-score was included in the model assessing the relation between FTO and height z-score 17 and fat mass z-score was included in the model assessing the relation between FTO and LBM z-score. P-values of less than 0.05 were considered statistically significant. All statistical analyses were performed using STATA 9.2 (Stata Corporation, College Station Texas; www.stata.com).
Results
Among the 1629 individuals under study at S-46, 21.4% were homozygous for the FTO rs9939609 A-allele ( Table 1 ). The MAF was 0.46 in S-46 and 0.45 in S-49, indicating that there was no genotype-dependent attrition. Furthermore, the MAF ranged from 0.45 to 0.47 in the preceding sub-cohorts, indicating that there was no genotype-dependent bias in availability of information at earlier ages. Logistic regression analyses revealed that the OR for being a homozygous carrier of the A-allele increased significantly with BMI z-score (measured as one unit changes) at all ages assessed during childhood (borderline significance at the age of 13 years) and adulthood. No association between carrier status and z-score for birth weight was observed (Figure 1) .
The increased BMI observed in homozygous individuals corresponded to an excess weight of approximately 5 kg at the age of 20 years and 6 kg at the age of 46 years when compared to heterozygote individuals and of 7 kg at the age of 20 years and 18 kg at the age of 46 years when compared with non-carriers.
Analysis of changes in BMI
The relation between the AA genotype and changes in BMI z-score from one assessment to the next are presented in Figure 1 as baseline-adjusted ORs. In accordance with the lack of an association with birth weight, the AA genotype was significantly associated with weight gain from birth to the age of 7 years (OR, 1.26; 95% CI, 1.09-1.44; P-value, 0.001). However, the AA genotype was not associated with further weight gain during childhood and adolescence (Figure 1) . From adolescence and early adulthood onwards, the AA genotype was associated with a second increase in BMI z-score, with ORs ranging from 1.12 (95% CI, 1.01-1.24; P-value, 0.04; 20-35 years) to 1.20 (95% CI, 1.01-1.44, P-value, 0.04; 13-35 years) (Figure 1 ). When analysing data on the basis of a co-dominant model, results for FTO and BMI remained the same (data not shown).
Analysis of height and changes in height Individuals with the AA genotype were significantly taller than individuals with the TT or TA genotypes during childhood and early adolescence, but achieved the same final height (Table 2 ). When stratifying the study population according to draft board BMI, the association between the genotype and height was only present among the obese at ages of 7 years (P-value, 0.046), 10 years (P-value, 0.047) and 13 years (P-value, 0.03). In logistic regression analyses, a significant association between the AA genotype and ageadjusted z-scores for height at 7 years (OR, 1.36; 95% CI, 1.06-1.74; P-value, 0.02) and 10 years (OR, 1.30; 95% CI, 1.01-1.66; P-value, 0.04) was observed, which was no longer present in early adulthood (mean age, 20 years; OR, 1.04; 95% CI, 0.92-1.17; P-value, 0.53) (Figure 2 ). The AA genotype was not associated with increment in height in any time interval during childhood or from childhood to adulthood, whereas an association with reduced linear growth from the age of 20 to 35 years (adjusted OR, 0.56; 95% CI, 0.35-0.92; P-value, 0.02) was observed ( Figure 2 ). Adjusting for BMI z-score weakened the association between the AA genotype and height z-score both at age of 7 (OR, 1.21; 95% CI, 0.92-1.58; P-value, 0.18) and 10 years (OR, 1.20; 95% CI, 0.92-1.57; P-value, 0.18).
A co-dominant model produced similar but no longer significant ORs with the strongest association between FTO and height seen at age of 13 years (OR, 1.19; 95% CI, 0.97-1.40).
Analysis of fat mass and LBM
As for BMI, the AA genotype was associated with fat mass both at S-46 (bioimpedance; OR, 1.21; 95% CI, 1.12-1.30; P-value, o0.0001) and S-49 (DXA; OR, 1.21; 95% CI, 1.08-1.36; P-value, 0.001). 18 Also, an association with increased LBM z-score at S-46 (OR, 1.24; 95% CI, 1.14-1.35; P-value, 3.4 Â 10
À7
; Figure 3 ) and S-49 (OR, 1.16; 95% CI, 1.02-1.32; P-value, 0.03) was observed. However, this association disappeared when adjusting for fat mass (S-46; OR, 1.14; 95% CI, 0.94-1.38; P-value, 0.18, respectively, S-49; OR, 0.98; 95% CI, 0.80-1.18; P-value, 0.80). 
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Discussion
This cohort study of Danish men assessed at eight points in time from birth to adulthood, revealed that the common FTO rs9939609, in addition to being related to fatness throughout life and in particular to weight gain during early childhood, was also positively associated with height in childhood and LBM in adulthood, mainly through the effect on fatness.
The primary strength of this study was the availability of longitudinal data from a unique study population created to represent a relatively high number of individuals from a very wide range of BMI in adolescence. In studies assessing 'the wide range' of BMI, the right end of the distribution Figure 1 Odds ratios with 95% confidence intervals for being a homozygous carrier of the FTO rs9939609 A-allele according to body mass index (BMI) z-score at eight points in time from birth to adulthood and according to increment in BMI z-score from one age to another (one unit changes, estimates adjusted for baseline z-scores).
FTO variant, weight dynamics and growth T Jess et al normally contributes with relatively few cases, and the purpose of our design was to assure an enrichment of the right tail (above the upper one percentile). The relatively small sample size may appear as a limitation to a genetic association study. However, being a random sample of the entire draft board population, the randomly selected part of the study sample available at the penultimate and ultimate survey actually represented populations of, respectively, 184 000 and 64 600 individuals, whereas the obese men (apart from differential non-participation) constituted all obese men at adolescence in this population and thereby further enriched the right end of the distribution. The statistical efficiency of this sampling design, when analysed as dichotomized case-control studies, corresponds to about half what would be achieved by investigating the full cohort, and when keeping the quantitative phenotypes, the efficiency is even higher. Another potential limitation of this study was the assessment of men only. However, in other Figure 2 Odds ratios with 95% confidence intervals for being a homozygous carrier of the FTO rs9939609 A-allele according to height z-score at five points in time from childhood to adulthood and to increment in height z-score from one age to another (one unit changes, estimates adjusted for baseline z-scores). FTO variant, weight dynamics and growth T Jess et al studies, no gender-related differences in the association between FTO and fatness have been observed. 6 Selective drop outFif genotype-dependentFcould also add bias to a longitudinal study as in this study. However, as blood for genotyping was drawn at the penultimate follow-up, this would maximally have affected longitudinal estimates from the age of 46 to 49 years, where the minor allele frequency was almost identical (0.46 and 0.45). Similar minor allele frequencies were observed in the preceding sub-cohorts indicating no genotype-dependent bias in availability of information at earlier ages. It may also be seen as a limitation that data tended to fit better with a recessive model than with the co-dominant used in former studies on FTO. This is likely due to the over-sampling of the right end of the distribution, where the AA genotype is expected to be richly represented. Analyses based on a co-dominant model produced estimates similar to those obtained using a recessive model. Finally, DXA scan and bioimpedance measurements should be interpreted with the awareness of the risk of measurement error.
In accordance with previous studies, [6] [7] [8] we observed a significant association between FTO and BMI z-score among school children, adolescents and adults, and no association between FTO and weight at birth. In this study, we had the unique opportunity to further test the association between FTO rs9939609 and weight dynamics during childhood and adulthood by assessment of a single cohort of individuals followed longitudinally from birth to the age of 49 years. During childhood, the AA genotype was associated with increase in BMI z-score from birth to the age of 7 years, but not from the age of 7 years and onwards. In early adulthood, a second FTO-associated increase in BMI z-score was observed. Hence, the overall impression is that the AA genotype induces fatness during early childhood, maintains a constant effect on BMI during later childhood, and facilitates further increase in BMI during adulthood. This is in accordance with a recent study suggesting that FTO causes development of fatness already in the neonatal period. 19 Later in life, factors such as low physical activity may influence the impact of FTO on the development of fatness, as suggested in a recent population-based study of 6104 Danes, where physical activity had been assessed by a questionnaire. 20 However, a following study from the same region with access to clinical measurements of fitness could not confirm this theory. 21 Hence, further studies are warranted to explore both the time period in early life, where FTO has its initial effect, and to reveal the mechanisms through which FTO induces further weight gain later in life.
In support of the hypothesis, that FTO may enhance general growth, individuals homozygous for the A-allele appeared to have accelerated linear growth in early childhood concomitantly with the observed weight gain. This association was, however, counterweighted by reduced linear growth after the age of 20 years, resulting in unaltered final height among individuals homozygous for the gene variant.
Similarly, Frayling et al. 6 observed a borderline-significant association between FTO and height at the age of 10 years (P ¼ 0.08) in a paediatric cohort, but no association between FTO and height in their adult cohorts. Other studies have shown that obesity in childhood is associated with accelerated linear growth and early pubertal development, 11, 22 probably due to hyperinsulinemia. 9 A parallel study of the present population has shown that individuals homozygous for the A-allele had decreased insulin sensitivity due to their fatness. 18 One could therefore hypothesize that linear growth is accelerated in childhood, but is limited in adolescence by early onset puberty with early closure of epiphyseal junctions, hence explaining the reduced growth in young adulthood and the resulting unaltered final height among individuals with the AA genotype. Although our results suggested that the association between the AA genotype and enhanced linear growth in childhood was mainly explained by the concomitant increase in fat mass, we also observed that among the subgroup of individuals, who had a BMI equal to or above 31 at the draft board examination, those carrying the AA genotype were significantly taller at the ages of 7, 10 and 13 years than obese carriers of the TT and TA genotypes. Further research is warranted to address whether these results were chance findings or true findings putatively related to the high expression of FTO in several human tissues including hypothalamus, 23 pituitary and adrenal glands. 7 Returning to BMI, it is recognized that this is only a surrogate measure for obesity, which apart from fat mass also reflects the size of LBM. 24 LBM becomes of interest when considering a general effect of FTO on growth. In this study, we demonstrated a significant association between FTO rs9939609 and LBM as measured by both bioimpedance and DXA at two different time points in adulthood. This association was explained by the FTO-induced increase in fat mass. Frayling et al. 6 had access to DXA measurement in 9-year-old children and observed that at this age, the association between FTO rs9939609 and increased weight was almost completely attributable to an increase in fat mass and not in LBM. However, it is well established that the weight gain that leads to overweight and obesity is not only composed of fat mass, but is actually made up of about 70-80% fat mass and 20-30% fat-free mass, the latter reflecting an increase in skeleton, muscle and organ size (heart, liver, kidney) as well as increased circulating blood volume and intercellular fluid volume. 25 In the context of FTO, both hyperinsulinemia and the carrying of an excess load of fat since childhood may therefore be expected to result in the observed fatness-explained increase in LBM in adulthood.
In conclusion, this longitudinal study of Danish men, representing a very broad range of BMI in a population of 184 000 Danish draftees, with repetitive anthropometric measures from birth to adulthood, confirmed that the A-allele of FTO rs9939609 predisposes to fatness early in childhood and revealed that this effect remains stable until early adulthood, when further weight gain may occur. In FTO variant, weight dynamics and growth T Jess et al addition, the gene variant mayFmainly through the effect on fatnessFbe associated with accelerated linear growth in childhood and increased LBM in adulthood.
